Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Asthma

• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
• Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
• An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604
• BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
• The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)
• Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
• Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma
• A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations
• Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
• Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
• AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
• Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma
• Effect of Incentive Spirometery on Asthmatic Pregnant Women
• In Vivo Efficacy of Salbutamol (Sandoz) Versus Salbutamol Ventolin (GSK) in Children With Asthma
• A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
• Study to Assess Bronchospasm Potentially Induced by HFO vs HFA MDI in Participants With Well/Partially Controlled Asthma
• EFFECTIVENESS OF SINGLE DOSE ORAL DEXAMETHASONE VERSUS MULTIDOSE PREDNISOLONE FOR TREATMENT OF ACUTE EXACERBATIONS OF ASTHMA AMONG CHILDREN ATTENDING THE EMERGENCY DEPARTMENT OF CHILDREN HOSPITAL, ISLAMABAD
• Huang-long Zhi-xiao Granule Improves the Control Rate of Chronic Persistent of Asthma
• Expertise Asthma COPD Program With Digital Support
• A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
• Efficacy of Sublingual Versus Subcutaneous Allergen Immunotherapy in Patients With Bronchial Asthma
• A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma
• A Study of CM326 in Subjects With Moderate to Severe Asthma
• A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.
• A Study of CM310 in Subjects With Moderate to Severe Asthma
• Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist
• A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
• A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
• A 24-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
• Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma
• Non-Inferiority,Combination Formoterol/FluticasonexAlenia®Formoterol/Budesonide for Asthma in Brazil
• Evaluation of 3D Magnetic Resonance Spirometry : Comparison to Spirometry in Healthy Subjects and Patients With Asthma and COPD
• Dupilumab Effects Against Aeroallergen Challenge
• Bacterial Lysate In Preventing Asthma
• A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
• Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers
• The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment With Placebo Using Improvement PRAM Score as a Primary Outcome
• Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
• A Phase III Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthm
• A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough
• Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects
• The Possible Efficacy and Safety of L-carnitine and Biotin as Adjunctive Therapies in Children With Moderate Persistent Asthma
• Symptoms Control and adhErenCe Assessment During Treatment With MepolizUmab New pREfilled Devices
• Poly-unsaturated Fats for Improving Nasal Polyps and Asthma
• Azithromycin Treatment for Non-eosinophilic Chest Tightness Variant Asthma
• A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma
• A Dose Ranging Placebo-controlled Double-blind Study to Evaluate the Safety, Pharmacokinetics and Efficacy of 610 in Participants With Severe Eosinophilic Asthma
• Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
• A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma
• Role of Parasympathetic Activity in Mild to Moderate Asthma With Irreversible or Fixed Airflow Obstruction
• A Phase II Study of 610 in Participants With Severe Eosinophilic Asthma
• A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Phenotype
• A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma
• A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma
• Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
• Multicenter Clinical Study on the Optimal Treatment Protocol and Outcome of Cough Variant Asthma With Chinese and Western Medicine
• Study of JYB1904 (an Anti-immunoglobulin E Antibody) in Healthy Chinese Subjects
• Safety and Biologic Impact (Pharmacodynamics) of Repeated Injections and Increasing Amounts of UPB-101 in Asthmatics
• Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma
• A Study of MG-K10 in Subjects With Asthma
• First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic Participants
• Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
• To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma
• Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
• Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
• BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient
• Intralymphatic Immunotherapy With Polvac Grass & Rye Allergen Extract
• Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
• Study of ARO-MUC5AC in Healthy Subjects and Patients With Asthma
• A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared to CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled Corticosteroid
• A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.
• Study of ARO-RAGE in Healthy Subjects and Patients With Asthma
• Study to Improve Deployment Related Asthma by Using L-Citrulline Supplementation
• Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
• Study to Assess the Efficacy and Safety of AZD5718 in Moderate-to-Severe Uncontrolled Asthma
• Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma
• A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS)
• A Study of CM310 in Subjects With Moderate to Severe Asthma
• Vitamin D Improves Clinical Manifestations in Asthmatic Children
• Timely Intravenous Magnesium for Asthma in Children
• Clinical Equivalence of Budesonide HFA MDI Versus Budesonide Turbuhaler in Mild to Moderate Chinese Asthma Patients
• Open Label, Observational Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab
• Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma
• Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
• Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
• A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists
• Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
• Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
• Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)
• Chinese Herbal Medicine Formula Combined With Inhaled Corticosteroids for the Treatment of Mild to Persistent Asthma in Children
• Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma
• A Trial of SHR-1703 in Asthma
• Effects of Interleukin (IL)- 4R-alpha Inhibition on Respiratory Microbiome and Immunologic Correlates in Severe Asthma
• Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
• Azithromycin Treatment of Hospitalized Children With Asthmatic Symptoms
• Step-up to Medium Strength Triple Therapy vs High Strength ICS/LABA in Adult Asthmatics Uncontrolled on Medium Strength ICS/LABA
• Single and Multiple Ascending Dose Study of KN-002
• EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients
• Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)
• Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma
• Terbutaline Sulfate in Adults With Asthma
• A Comparative Study on the Efficacy of Different Stepping-down Therapy for Childhood Asthma
• Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
• Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma
• Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
• EDP1867 Phase 1a/1b Study in Healthy Participants and Participants With Moderate Atopic Dermatitis and, Optionally, Moderate Psoriasis, and/or Mild Asthma
• Phase I Clinical Trial of TQC2731 Injection
• Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma
• A Trial of SHR-1905 in Healthy Subjects and Subjects With Mild Asthma
• This is a Phase 1 Study to Compare Pharmacokinetics of BDA/MDI Compared to Pulmicort Respules in Children With Asthma Aged 4 to 8 Years
• A Study to Test if TEV-53275 is Effective in Relieving Asthma
• A Study to Assess the Pulmonary Safety of Staccato Alprazolam in Healthy Study Participants and in Study Participants With Mild Asthma
• A Study Assessing the Efficacy and Safety of CBP-201 in Patients With Moderate to Severe Persistent Asthma With Type 2 Inflammation
• A Clinical Trial in Healthy Volunteers to Investigate a New Medicine (AZD4604) for the Treatment of Asthma
• Short Treatment With Omalizumab for Severe Asthma
• Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
• A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Trial to Assess the Safety and Efficacy of Subjects With Mild Asthma Induced by the Bronchial Allergen Challenge (BAC)
• Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
• A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype
• A Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype
• Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation
• A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)
• A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Patients 13 Years or Older With Asthma
• XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma
• A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS® 100mcg/Blister Oral Inhalation Powder/GSK in Patients With Asthma
• Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma
• Tiotropium Efficacy Against Allergen Induced Early Asthmatic Responses
• Efficacy and Safety of Three Inhaled Dose Levels of AZD1402 Administered for Four Weeks in Adults With Asthma on Medium Dose Inhaled Corticosteroids
• Benralizumab Initiated During Severe Asthma Attack
• Defining and Treating Depression-related Asthma
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)
• Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)
• Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma
• Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab".
• Safety, Tolerability and Pharmacokinetics of GSK3923868 Inhalation Powder in Healthy Participants and Stable Asthmatics
• Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
• Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma
• Predictive Signature of Benralizumab Response
• A Study to Test if TEV-48574 is Effective in Relieving Asthma
• Study to Assess the Safety and Efficacy of SelK2 on Airway Responses Following Allergen Challenge in Subjects With Asthma (Part 1) and in Subjects With Chronic Obstructive Pulmonary Disease (Part 2)
• Airway Microbiota Based Treatment of Asthma in Preschool Children
• A Clinical Study on the Prevention of Mild to Moderate Intermittent Asthma With Chinese Medicine Weiyang Yuping Fang
• Oxidative Stress in Asthma
• Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma
• Dupilumab Asthma Sleep Study
• Comparasion of Efficacy of Nebulized With Intravenous Magnesium Sulphate in Children With Asthma
• Double Dose Magnesium Sulphate in Moderate-severe Asthma in Paediatrics
• Vitamin D Regulates the Expression of Glucocorticoid Receptors in Blood of Severe Asthmatic Patients
• Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
• The Effect of Dupilumab on Lung Function and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe Asthma
• Viral Infection in Asthma (VIA) Study
• Evaluating Effects of Curcumin in Moderate to Severe Asthmatics
• Clinical Characteristics and Treatment of Chest Tightness Variant Asthma
• Anti-viral Effects of Azithromycin in Patients With Asthma and COPD
• PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma
• Phase 4 Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Subjects Aged >=18 Years With Severe Eosinophilic Asthma Requiring Maintenance Oral Corticosteroids
• Fluticasone-Vilanterol as Needed for the Treatment of Mild Asthma in Adults
• Anti-inflammatory Effects Glycopyrronium
• A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment
• A Pragmatic Study to Investigate the Efficacy and Safety of Mepolizumab in Severe Uncontrolled Asthma in Brazil
• As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period
• A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma
• A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
• Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma
• Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma
• A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled Allergen
• Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications
• Mechanisms for Dyspnea on Exertion in Children With Obesity and Asthma: Distinct Physiological Phenotypes
• Personalized Treatment Algorithms for Difficult-to-treat Asthma
• The Efficacy of Budesonide/Formoterol in Cough Variant Asthma
• Regular Use Effect of Inhaled Ipratropium Bromide on Airway Responsiveness to Methacholine in Well-controlled Asthma
• 5HTP Regulation Of Asthma In Children
• A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab
• Effect of Inhaled TD-8236 on Allergen-induced Asthmatic Response
• PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study
• Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy
• Benralizumab in the Treatment of Patients With Severe Asthma With ABPA
• Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
• Benralizumab Exacerbation Study
• The Effect of Allergen Immunotherapy on Anti-viral Immunity in Patients With Allergic Asthma
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
• A Clinical Study to Test the Safety, Exposure, and Pharmacodynamic Markers of CSL311 in Patients With Mild Asthma and in Healthy Volunteers
• Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH
• Efficacy and Safety of CHF 6532 in Patients With Uncontrolled Severe Eosinophilic Asthma
• Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
• Dexpramipexole Dose-Ranging Biomarker Study in Subjects With Eosinophilic Asthma
• MitoQ for the Treatment of Metabolic Dysfunction in Asthma
• Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma
• A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma
• Symptom Clusters in Children With Exacerbation-prone Asthma
• A Cross-sectional Study to Measure Cough in Severe Asthma
• Use of DNAse in Neutrophilic Asthma
• Mechanistic Study of Anti-inflammatory Effects of Fevipiprant in Patients With Eosinophilic Asthma.
• A Study to Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma
• CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients
• Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma
• ED-Initiated School-based Asthma Medication Supervision
• Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients
• GSNOR Phenotyping/GSNO Challenge in Severe Asthma
• Ideal Steroids for Asthma Treatment in the PICU
• A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Patients 13 Years or Older With Asthma
• Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
• Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
• Cysteamine for Asthma
• This Study Include Asthma Chronic Obstructive Pulmonary Disease (COPD) Overlap Patients.Patients Were Vitamin D Deficient.Age Range 40-70 Years, Smokers.Patients Were Advised to Take Either Placebo or Vitamin D3.Lung Functions and Exercise Tolerance
• Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg
• Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With Asthma
• Trial of Tauroursodeoxycholic Acid (TUDCA) in Asthma
• The Effect of FP-025, a MMP-12 Inhibitor, on Allergen-induced Airway Responses and Airway Inflammation in Mild Eosinophilic House Dust Mite (HDM)-Allergic Asthma
• A Study of MRx-4DP0004 in Asthma
• A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered Dose Inhaler (BDA MDI/PT027) Used 4 Times Daily in Adults and Children 4 Years of Age or Older With Asthma
• The Mannitol-Asthma-Ciclesonide-Study
• Study in Cat-Allergic Patients With Asthma to Evaluate the Efficacy of a Single Dose of REGN1908-1909 to Reduce Bronchoconstriction Upon Cat Allergen Challenge
• Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Mild to Moderate Persistent Asthma
• Beclomethasone Dipropionate HFA in Adult and Adolescent Subjects With Persistent Asthma
• Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children
• The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma
• Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma
• Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients
• Masitinib in the Treatment of Patients With Severe Uncontrolled Asthma and Elevated Eosinophil Levels
• A Study in Healthy Volunteers and Patients With Mild Asthma to Investigate the Safety, Anti-inflammatory Effect of Inhaled AZD0449
• MAPS & ITEC Cohorts: 6-8 Years Follow-up
• Anti Inflammatory Lipid Mediators in Asthma
• Therapeutic Equivalence of Two Formulations of Fluticasone Propionate and Salmeterol Inhalation Powder in Subjects With Asthma
• The Effect of PC945 on Aspergillus or Candida Lung Infections in Patients With Asthma or Chronic Respiratory Diseases
• Azithromycin Treatment for the Airway Microbiome in Asthma
• Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
• Treatment With the Anti-IgE Monoclonal Antibody Omalizumab in Women With Asthma Undergoing Fertility Treatment. - A Proof of Concept Study.
• A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
• Ginger's Therapeutic Potential in Asthma
• Comparison of Dexamethasone Oral Preparations to Assess Taste and Acceptance in Children With Asthma and Croup
• Investigating Dupilumab's Effect in Asthma by Genotype
• GB001 in Adult Subjects With Moderate to Severe Asthma
• Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma
• A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
• Soluble Corn Fiber Supplementation for Asthma
• Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
• Pharmacokinetics, Safety and Tolerability of Fevipiprant Delivered Via a Once Daily Chewable Tablet in Children Aged 6 to < 12 Years With Asthma
• Safety and Efficacy of Albuterol Administered by the Halix™ Dry Powder Inhaler in Subjects With Asthma
• Systemic Corticosteroids Avoidance Study in Severe Asthma Patients
• A Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD7594 Administered Once Daily by Inhalation in Asthmatic Subjects
• Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)
• Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
• Project 2 Airway Potential Hydrogen (pH) in Asthma
• Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma
• Reducing Exercise-induced Bronchoconstriction in Children With Asthma and Obesity
• Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma
• Single and Multiple Doses of HA115 and Food Effect in Healthy Adult Volunteers
• Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)
• A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation Aerosol
• A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
• A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma
• Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)
• Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base
• Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
• Clinical Endpoint Bioequivalence Study of Fluticasone Propionate & Salmeterol Xinafoate (100μg/50μg)
• Trial of Roflumilast in Asthma Management (TRIM)
• A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
• Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO
• Status Asthmaticus on the PICU; Intravenous Salbutamol
• Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma
• An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma
• Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
• Proof of Concept Study to Investigate ANB020 Activity in Adult Patients With Severe Eosinophilic Asthma
• Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.
• Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma
• Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.
• XC8 in the Treatment of Patients With Bronchial Asthma
• Effects of Noninvasive Ventilation Compared to Salbutamol
• BE Study of Fluticasone Propionate/Salmeterol Inhalation Powder in Asthma Patients
• The Safety and Efficacy of Intralymphatic Immunotherapy in Pollen Allergic Adolescents and Young Adults With Asthma
• Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)
• Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants
• Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years
• Role of Montelukast in Asthma and Allergic Rhinitis Patients
• A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects
• Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma
• Montelukast and Loratadine in Children With Asthma
• Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
• Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
• Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children
• Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
• The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma
• Efficacy and Safety of PT001 to Placebo and Open-label Spiriva® Respimat® in Subjects With Persistant Asthma
• Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban
• Down-titration of Steroids in Patients With Difficult Asthma With no Bronchial Hyperreactivity
• Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.
• PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD
• Study to Assess the Efficacy and Safety of CJM112 in Patients With Inadequately Controlled Severe Asthma
• A Study to Assess Jia Wei Yang He Formula as a Plus Therapy in the Treatment of Persistent Asthma
• Study Examining PrEP-001 in Subjects With Asthma
• Non-invasive Ventilation vs. Standard Therapy for Children Hospitalized With an Acute Exacerbation of Asthma
• A Trial of Mepolizumab Adjunctive Therapy for the Prevention of Asthma Exacerbations in Urban Children
• First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma
• Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
• To Assess the Pharmacokinetics, Safety and Tolerability of Abediterol Administered Once Daily for 9 Days, in Patients With Asthma on Inhaled Corticosteroids
• PRISTINE - Personalised Approach to Improve aSThma prescrIbing iN childrEn
• Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
• Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma
• Clinical Study on Treatment of Chronic Persistent Bronchial Asthma
• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
• Study of Efficacy and Safety of QAW039 When Added to Standard-of-care Asthma Therapy in Patients With Uncontrolled Asthma
• Interrelation Between Bronchial Asthma and Smoking
• Efficacy and Safety Study of GSK3772847 in Subjects With Moderately Severe Asthma
• Steroids In The Management Of Acute Asthma Exacerbations In Children, Which Form Is More Suitable?
• A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma
• A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.
• Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium
• Undiagnosed COPD and Asthma Population Study (UCAP)
• Periostin-guided Withdrawal of Inhaled Corticosteroids in Patients With Non-eosinophilic Asthma
• A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898
• A Bronchoprovocation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CSJ117 in Adult Subjects With Mild Atopic Asthma
• Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
• Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)
• BI 443651 Methacholine Challenge
• Dexamethasone Versus Prednisone for Asthma Treatment in the Pediatric Inpatient Population; a Feasibility Study
• Pemirolast in Allergen Challenge (PEMAG)
• Study of REGN3500 and Dupilumab in Patients With Asthma
• Clinical Trial on Education Method of Fluterol® Inhalation Inhaler for Asthma Control
• A Study to Evaluate the Onset of Relief From Methacholine-induced Bronchoconstriction With CHF1535 NEXThaler in Asthmatic Patients.
• Assess Bronchodilator Effect QVM149 Dosed Either in the Morning or Evening Compared to Placebo in Patients With Asthma
• Sensory-Mechanical Responses to Eucapneic Voluntary Hyperventilation and Hypertonic Saline
• A Long-term Safety Study of QVM149 in Japanese Patients With Asthma
• A Long-term Safety Study of QMF149 in Japanese Participants With Asthma
• Study of Mepolizumab Autoinjector in Asthmatics
• TEAM (Trial on Efficacy and Quality of Life Among Asthmatic Patient With Montelukast)
• A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
• An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
• Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab
• Assess Bronchodilator Effect and Safety of Two Doses of QVM149 Compared to a Fixed Dose Combination of Salmeterol/Fluticasone in Patients With Asthma.
• A First Time in Human Study of PIN201104 in Healthy Volunteers and Patients With Asthma
• A Study of Reslizumab in Patients 12 Years of Age and Older With Severe Eosinophilic Asthma
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment
• C1-inhibitor in Allergic ASThma Patients
• The RECONSTRUCT Study - Reconstructing Disease Mechanisms in Asthma
• Study of Mepolizumab Safety Syringe in Asthmatics
• The Effect of Probiotics on Asthma Risk in Animal Laboratory Workers
• Genotype-tailored Treatment of Symptomatic Acid-Reflux in Children With Uncontrolled Asthma
• Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients
• Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma
• Response of the Airway in Sinusitis and Asthma
• Study of Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of REGN3500 in Adults With Moderate Asthma
• Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
• Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects
• Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
• A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma
• Influenza Vaccine Feasibility Study in Children With Persistent Asthma
• Effects of Intranasal Fluticasone Plus Azelastine on Airway Inflammation in Patients With Asthma & Allergic Rhinitis
• Evaluation of Dupilumab in Children With Uncontrolled Asthma
• Study on the Treatment of Bronchial Asthma With Traditional Chinese Medicine
• An Imaging Study Using PET/CT to Characterize the Effect of Intravenous Reslizumab on Airway Inflammation
• Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients
• A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled
• Smoking Cessation Intervention in Respiratory Inpatients
• Role of Herbs in the Management of Asthma
• A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe Asthma
• Aspirin for Uncontrolled Asthma
• AZD1419 Ph2a Study
• Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma
• Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma
• Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a Year
• Study to Assess Pharmacokinetics, Safety, and Tolerability of XC-8
• Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis
• Evaluating the Safety and Feasibility of TLD for the Treatment of Moderate to Severe Refractory Asthma
• A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation
• Asthma Control Test Guided Treatment in Chinese Subjects
• Safety of Nasal Influenza Immunisation in Children With Asthma
• Busonid® (Budesonide 200 mcg and 400 mcg) to Treat Asthma Not Controlled or Partially Controlled
• Effect of the GSK2245035 on the Allergen-induced Asthmatic Response
• Study to Evaluate the Potential Effect of Benralizumab on the Humoral Immune Response to the Seasonal Influenza Vaccination in Adolescent and Young Adult Patients With Severe Asthma
• Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
• Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)
• A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma
• Steroids in Children Hospitalized With Asthma
• A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma
• Low Exhaled NO and ICS in Suspected Asthma
• Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma
• Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
• A Study to Evaluate the Effect of Fluticasone/Formoterol Breath Actuated Inhaler (BAI) or Relvar® Ellipta® DPI on Ventilation Heterogeneity in Asthma
• A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic Asthma
• The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children
• Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)
• Biomarkers of Irritant-Induced and Allergic Asthma
• In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma
• To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children
• Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB)
• Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma
• Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation
• Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)
• A Phase IIA FF/VI Study to Measure FeNO in Asthmatic Patients.
• Effects of Anti-TSLP in Patients With Asthma
• Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)
• Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics
• A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With Asthma
• Changes in the Lung Clearance Index in Pediatric Patients With Asthma
• TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)
• TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA
• Characterising the Microbiota in Asthma
• Vitamin D Deficiency and Asthma Exacerbation
• Effect of OC459 on the Response to Rhinovirus Challenge in Asthma
• Sputum-derived Cellular Targets After Xolair (Omalizumab)
• Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients
• Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
• A Study to Assess the Efficacy of a 5-day, 10- mg PBF-680 Oral Administration on Late Asthmatic Responses (LAR) in Mild to Moderate Asthmatic Patients.
• Asthma in the Elderly: The Effect of Montelukast
• A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
• Asthma Exacerbations and Vascular Function
• Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
• Safety and Efficacy of CRD007 in Adult Asthma Subjects
• RSPR-007 Mannitol Challenge Trial
• Clinical Trial of NAC in Asthma
• A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK HDM Tablets in Adult Subjects With HDM-Induced Allergic Rhinitis and/or Atopic Asthma
• Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
• Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma
• Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation
• Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
• Efficacy Study of Acupoint Sticking in Summer to Treat Asthma
• Effect of Extra- Fine Versus Coarse-Particle Inhaled Corticosteroids (ICS) on Ventilation Heterogeneity in Children With Poorly Controlled Asthma
• Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics
• Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
• Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects
• Study to Compare the Efficacy and Safety of QVM149 With QMF149 in Patients With Asthma
• Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma
• Preventing Asthma in High Risk Kids
• Comparison of Breath-Enhanced and T-Piece Nebulizers in Children With Acute Asthma
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
• Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
• Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
• ICS/LABA Combination With Integrated Dose Counter and Smartphone APP to Improve Asthma Control
• Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.
• Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma
• This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Acces
• Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
• Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
• A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153
• Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
• A Study to Evaluate the Pharmacokinetics of MEDI9929 (AMG 157) in Adolescents With Mild to Moderate Asthma
• Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
• An Efficacy and Safety Study of Reslizumab Subcutaneous in Patients With Oral Corticosteroid Dependent Asthma and Elevated Blood Eosinophils
• Repeat Emergency Department Visits Among Patients With Asthma and COPD
• Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics
• Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
• Positive Expiratory Pressure for the Treatment of Acute Asthma in Children
• Small Airway Function of Fluticasone/Formoterol (Flutiform®) and Fluticasone/Salmeterol
• A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
• Specific Use-result Surveillance of Spiriva Respimat in Asthmatics
• Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma
• A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma
• An Open Study to Assess the Robustness of the CRC749 Inhaler
• An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma
• Trial of AccuPAP Device Versus Standard Nebulizer Therapy in Acute Asthma Exacerbation in Children
• Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.
• Study of Reslizumab in Participants With Uncontrolled Asthma and Elevated Blood Eosinophils
• A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma
• Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma
• Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age
• The Effects of NOx and Conjugated Linoleic Acid on Asthmatics
• Chronic Dosing Cross-Over Study to Assess the Efficacy and Safety of Glycopyrronium (PT001) in Adult Subjects With Intermittent Asthma or Mild to Moderate Persistent Asthma
• Trial of Simvastatin for the Treatment of Severe Asthma
• Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients
• Effect of Vitamin D as add-on Therapy for Vitamin D Insufficient Patients With Severe Asthma
• Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
• Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease
• Effect of Inhaled Mometasone/Formoterol Versus Inhaled Fluticasone/Salmeterol in Asthma Patients
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)
• Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus
• Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
• Pharmacokinetics and Pharmacodynamics of Mepolizumab Administered Subcutaneously in Children
• Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis
• A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis
• Experienced Chinese Herbal Formulas on Pediatric Asthma
• Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma
• Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma
• Airway Response to Repeat Allergen Challenge and the Effect of Ibuprofen in Mild Atopic Asthma
• Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3
• AMP-BPT and His-BPT for Assessment of Asthma
• An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents W
• Efficacy of LAMA Added to ICS in Treatment of Asthma
• Cross-sectional Study for Identification and Description of Severe Asthma Patients
• Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
• Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers
• A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics
• Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma
• Environmental Control as Add-on Therapy in Childhood Asthma
• The Effect of BIIL 284 BS on Induced-sputum Variables in Patients With Bronchial Asthma
• MGR001 / Advair Diskus Local Equivalence Study in Asthma
• Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
• Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children
• A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma
• Alendronate to Prevent Loss of Bronchoprotection in Asthma
• Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients
• A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma
• Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)
• An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma
• A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler
• Pharmacokinetic Profile of Four Formulations of Fluticasone Furoate (FF) Using Unit Dose Dry Powder Inhaler (UD-DPI) Compared With FF ELLIPTA® Presentation
• Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
• Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of PBF-680 After Multiple Oral Doses"
• Use of Dexamethasone in Pediatric Asthma Exacerbations
• Efficacy and Safety of Combivent® Aerosol and Spacer, in Adult Patients With Moderate to Severe Asthma Crisis
• A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma
• Safety and Efficacy of Berodual® Inhaled Via Respimat® Compared to MDI (Metered Dose Inhaler) in Pediatric Patients With Asthma
• Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients
• Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy
• Effect on Fenoterol Metered Dose Inhaler on the Beta-receptor Population on Lymphocytes in Patients With Bronchial Asthma
• Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Propionate/Salmeterol (FS) MDPI in Patients With Persistent Asthma
• Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition
• Aerosolized Beta-Agonist Isomers in Asthma
• Efficacy Study of SYN006 HFA MDI in Asthma Patients
• Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
• A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects
• A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
• Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729 for up to 28 Days
• Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
• A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)
• Triple in Asthma Dose Finding
• Study of Efficacy and Safety of NVA237 in Patients With Poorly Controlled Asthma
• Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients
• A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics
• Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma
• Efficacy and Safety of Fluticasone Propionate(FP)/ Salmeterol Xinafoate (SLM) Hydro Fluoro Alkane (HFA) Metered Dose Inhaler (MDI) in Pediatric Patients With Bronchial Asthma
• Compare Efficacy Nebulized and Intravenous Magnesium Sulphate in Thai Children
• Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery
• Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma
• A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
• A Study to Evaluate Efficacy and Safety of Methacholine Chloride Challenge Test in Diagnosis of Adult Asthma
• A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma
• Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma
• A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects
• A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
• Thyroid Hormones Treatment in Asthma Exacerbation
• Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201
• The Various Effects of Gaseous Albuterol on Serum Lactate
• Steroids In Eosinophil Negative Asthma
• Step-up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations
• Knemometry Study to Compare the Systemic Safety of Flutiform pMDI, Fluticasone pMDI and Beclometasone Autohaler in Paediatric Subjects Aged 5 to Less Than 12 Years.
• Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma
• Use of Mobile Devices and the Internet to Streamline an Asthma Clinical Trial
• Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD
• Vitamin D in Pediatric Asthma: a Randomized Controlled Open-label Pilot Trial
• Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma
• Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital
• Improving Asthma Control in the Real World: A Systematic Approach to Improving Dulera Adherence
• Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316
• A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-Actuated Inhaler (BAI) in Patients >=12 Years Old With Persistent Asthma
• A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma
• Ultra-long Acting Bronchodilator Therapy in Asthmatics
• A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
• Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast Sodium)to Treat Asthma
• Safety, Tolerability and Pharmacokinetics of Inhaled Laninamivir Octanoate TwinCaps® DPI in Adults With Chronic Asthma
• Azithromycin for Children Hospitalized With Asthma
• The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma
• Supervised Asthma Medication in Schools (SAMS)
• A Study to Evaluate the Effect of Gefapixant (AF-219/MK-7264) on Methacholine Hyper-reactivity in Participants With Asthma (MK-7264-009)
• A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
• Anti-histamines and Methacholine Challenges.
• Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.
• Does Asthma Phenotype Have Impact on Disease Control
• A Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol (FSC) 250/50 Microgram (mcg) Twice Daily (BID) in Adults and Adolescents With Asthma
• Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma
• Asthma Biomarkers for Predicting Response to Therapy
• Best African American Response to Asthma Drugs
• Leukotriene D4 Nasal Provocation Test in Allergic Rhinitis
• Stepping Down of Asthma Medication in Controlled Asthma
• Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
• Effect of Clopidogrel on Allergen Challenge in Asthma
• Effects of Montelukast on Airway Regulatory T Cells in Asthma
• Comparison of Nebulizers in ED in Pediatric Asthma Patients
• Bronchodilator Properties and Safety in Asthma
• A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma
• A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma.
• A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)
• Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma
• Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
• Study Phase III Study to Assess the Efficacy and Safety of SOTB07 in Asthma Patients
• Dose-Response of Salmeterol in Children
• Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
• Targeted Small Airways Therapy in Persistent Asthma
• Effects of Particle Size in Small Airways Dysfunction
• ROTAHALER Device Optimization Study
• A Phase IIa Repeat Dose AXP1275 vs Placebo Cross-over Trial With Pulmonary Allergen Challenge in Adults With Asthma
• Distribution of Neutrophils in Bronchial Mucosal Tissue in Asthma Patients Before and After 4 Weeks Treatment With AZD 5069
• Inhaled Steroids at Discharge After Emergency Department Visits for Children With Uncontrolled Asthma
• Qvar vs FP in Pediatrics
• A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
• Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
• The Effect of Aspirin Desensitization on Patients With Aspirin-exacerbated Respiratory Diseases
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
• Bioequivalence Study of Montelukast 5 mg Chewable
• Lung Function Changes of Induced Asthma Children Treated With Inhaled MgSO4
• An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
• Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old
• Human Rhinovirus Infection and Airway Remodeling Mediators
• A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture
• "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers
• Study of Safety of Foradil in Patients With Persistent Asthma
• Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
• L-arginine in Severe Asthma Patients Grouped by Exhaled Nitric Oxide Levels
• A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma
• Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
• A Study to Assess the Bronchodilator Effect of a Single Dose of Fluticasone Furoate (FF)/ Vilanterol (VI) 100/25 Micrograms (mcg) Combination When Administered in Adult Patients With Asthma
• A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients
• MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
• Bronchial Thermoplasty for Severe Asthmatics Guided by HXe MRI
• A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
• Safety and Efficacy of WIN-901X in Asthma
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of RV1729
• To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma
• Single Dose Bronchodilatory Study in Asthma
• Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma
• Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®
• Single-Dose Clinical Pharmacology Study in Asthmatic Adolescent and Adult Patients
• Lung Function of Asthmatic Children by Nebulized MgSO4
• Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients
• Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma
• Acid-suppressing Drugs Pregnancy Asthma Offspring Study
• Polymorphism of beta2-adrenoceptor and Regular Use of Formoterol in Asthma
• Study of Bronchodilation Effects of Cetirizine
• Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects
• Roflumilast Plus Montelukast in Adults With Severe Asthma
• CSL311 and Cell Viability in Asthma
• Implications and Stability of Clinical and Molecular Phenotypes of Severe Asthma
• Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
• Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)
• Effects of QVAR in Smokers With Asthma
• Safety and Efficacy of SA09012 in Asthma
• Lung Bioavailability and Total Systemic Exposure to Beclomethasone17MonoPropionate and Formoterol Across Two Strengths of NEXThaler Inhalation Powder
• Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma
• Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
• Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).
• Electrophilic Fatty Acid Derivatives in Asthma
• A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled Asthma
• Change of Airway Hyperresponsiveness to Mannitol and Methacholine in Patients With Asthma
• Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma
• Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
• Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom
• Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen
• An Effectiveness Study Comparing Fluticasone Furoate (FF, GW685698)/Vilanterol (VI, GW642444) With Standard Treatment in Asthma
• Intramuscular Epinephrine as an Adjunctive Treatment for Severe Pediatric Asthma Exacerbation
• A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
• A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16
• A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
• Change in Airway Responsiveness After Allergen Exposure
• Safety Study of Albuterol Spiromax® in Subjects With Asthma
• Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy
• A Pilot Study to Determine the Feasibility and Utility of Implementing of the Full Scale TOM Trial
• Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication
• Effect of an add-on Treatment With Ivy Leaves Dry Extract on Lung Function in Bronchial Asthma
• MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects
• Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma
• Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma
• A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics
• Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma
• Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma
• An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma.
• WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and Outcomes
• Challenge Test for Acetylsalicylic Acid Hypersensitivity
• Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled Asthma
• The Clinical Effect of Monodisperse Fluticasone Propionate in Asthma
• Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
• A Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
• A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)
• A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects
• Aura Adolescent PK Study GSK2829332
• Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients
• Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients
• Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
• Children With HIV and Asthma (CHIVAS)
• A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma
• Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
• Onset and Duration of Mometasone by Oscillometry and Spirometry
• Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma
• Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects
• Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)
• Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
• Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study
• Effects of Montelukast in Asthmatic Children With and Without Food Allergy
• Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
• Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)
• Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma
• Acetaminophen Versus Ibuprofen in Children With Asthma
• Individualized Therapy For Asthma in Toddlers
• Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
• A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma
• Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma
• Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma
• Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
• A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)
• Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.
• Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation
• Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma
• Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
• Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children
• Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma
• A Study in Patients With Asthma
• To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma
• Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)
• A Dose-ranging Study of Fluticasone Furoate (FF)
• A Study of ARRY-502 in Patients With Persistent Asthma
• Borage and Echium Seed Oils for Asthma
• Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 Device or Twisthaler® Device in Adult and Adolescent Patients With Persistent Asthma
• Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
• A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma
• Sunovion Growth Study Pediatric Subjects With Mild Asthma & Allergic Rhinitis
• Imaging Study of the Lungs During an Allergic Asthma Attack
• Safety and Efficacy of QAW039 in Sputum Eosinophilia and Persistent Asthma
• A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
• A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
• Beta Blocker Therapy in Mild to Moderate Asthmatics
• A Single Centre Study in Healthy Volunteers to Optimise the Rotacap Formulation and ROTAHALER Device for Delivery of Fluticasone Propionate/Salmeterol
• Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment
• A Placebo and Active Controlled Study of ONO-6950 in Asthmatic Patients
• The Use of FKBP51 in the Identification of Non-adherence to Inhaled Corticosteroids in Difficult Asthma
• Management of Asthma in School-age Children on Therapy
• Effects of Whole Sprouts on Airway Allergic Inflammation
• Pilot Study of Magnesium Infusions in Pediatric Asthma
• Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients
• Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth
• Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations
• A 12-Week Study in Adult Subjects With Asthma
• 12-Week Study in Adult Subjects With Asthma
• Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation
• AMG 761 in Adults With Asthma
• Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients
• Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
• Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
• A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
• Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
• A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.
• Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry
• Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic
• Study of JNJ-39758979 in Symptomatic Adult Patients With Uncontrolled Asthma
• Comparison of Two Treatment Regimens in Asthmatic Patients
• Role of microRNAs in T Cell-Driven Inflammation in Asthma
• Single Dose Study of the Fluticasone/Salmeterol (500/50 μg) Administered With Elpenhaler® Versus Diskus®
• A Study to Evaluate the Effects of Indacaterol Maleate as a New Formulation in the Concept 1 Device
• A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
• A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma
• Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma
• Safety Study in Adolescent and Adult Patients With Asthma
• SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
• Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children
• Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma
• GSK2190915 Neutrophilic Asthma Study
• A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)
• Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects
• Clinical Pharmacology of CHF 1535 50/6 ug Next DPI in Children 5-11 Years Old
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
• Evaluation of Efficacy and Safety of E004 in Children With Asthma
• Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroids
• Study on BI 54903 (Inhaled Corticosteroid) Administered Once Daily or Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Short Acting Beta-2 Agonist (SABA) Therapy Alone
• Effect of High Dose Ciclesonide on Asthma Control
• Pharmacokinetics and Pharacodynamics of GW642444 in Paedetric Subjects
• Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD Study
• Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
• Masitinib in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids
• Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
• Vitamin and Asthma Study
• AZithromycin Against pLacebo in Exacerbations of Asthma
• A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents
• Long-acting Beta Agonist Step Down Study
• Dose Finding Study for QAW039 in Asthma
• A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma
• A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise
• House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma
• Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and Adolescents
• Observed Outcomes Associated With Fluticasone Propionate/Salmeterol Xinafoate or Inhaled Corticosteroids in Asthma Patients
• Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
• Magnesium Nebulization Utilization in Management of Pediatric Asthma
• Olodaterol Bridging Study in Asthma
• Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.
• A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
• Single Dose Study of GSK1440115 in Patients With Asthma
• Safety and Efficacy of YHD001 in Asthma
• Phase I Pharmacokinetic Study (BF-BLOCK)
• Leukotriene D4 Bronchial Provocation Test (LTD4-BPT) as an Indicator for the Use of Leukotriene Receptor Antagonist (LTRA)
• A Phase IIa Study of KHK4563
• A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin
• Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma
• Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma
• A Phase 2b, Randomized, Double-blind Study to Evaluate the Efficacy of Tralokinumab in Adults With Asthma
• Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.
• Qvar Versus Clenil, a General Practice Research Database Study
• Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)
• Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
• Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).
• Rapid vs Maintenance Vitamin D Supplementation in Deficient Children With Asthma to Prevent Exacerbations.
• Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma
• Clinical and Biological Effects of Anti-IgE (Omalizumab) in Patients With Bilateral Nasal Polyposis and Asthma
• Characterization of the Role of Histamine in Children With Asthma
• A Study to Assess Safety and Efficacy of a Novel Treatment, Keratinocyte Growth Factor (KGF), in Asthmatic Patients
• Asthma Phenotypes in the Inner City
• Intravenous Magnesium in Wheezy Bronchitis
• A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma
• A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma
• Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma
• Pilot Pharmacokinetic Clenil Study With AeroChamber Plus™ or Volumatic™ Spacer Devices
• A Study to Evaluate the Effect of Roflumilast on Airway Inflammation and Function Following Allergen Challenge in Subjects With Allergic Asthma
• Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients
• 2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma
• Evaluation of the Pharmacokinetics and the Pharmacodynamics of Different Dry Powder Inhalation Formulations of AZD3199 in Patients With Asthma
• Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy
• Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients
• Efficacy of CHF1535 Via NEXT DPI Versus pMDI and BDP DPI100µg on PeakExpiratoryFlow in Asthmatic Patients
• A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)
• Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma
• Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of Asthma
• Cost-effectiveness Study of Beclomethasone Versus Ciclesonide as Controller Medications in Pediatric Asthma
• Outcomes in Patients Taking Fluticasone Propionate/Salmeterol Combination or Other Inhaled Corticosteroids
• Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients
• The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
• Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care Population
• Long-term Safety, Tolerability and Efficacy of Omalizumab in Japanese Children
• Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia
• Antidepressant Treatment at an Inner City Asthma Clinic
• GSK BHR Study (Sont - Second Study)
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma
• Study to Evaluate the Bronchoprotective Effects of a Single Dose of N6022 in Patients With Mild Asthma
• Device Mixing in Asthma, a General Practice Research Database Study
• Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic Asthma
• A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
• A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways
• The Effect of Prasugrel on Bronchial Hyperreactivity and on Markers of Inflammation in Patients With Chronic Asthma
• Effect of Addition of Single Dose of Oral Montelukast to Standard Treatment in Acute Asthma in Preschool Children.
• Cross-Over Study of Subcutaneous Study Drug for the Treatment of Patients With Mild to Moderate Asthma
• A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge
• TC-6987 for the Treatment of Mild to Moderate Asthma
• Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.
• Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
• Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)
• Real-world Effectiveness and Cost-effectiveness of Qvar Versus FP, a US Study
• A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
• GSK2190915 Pediatric Study
• A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
• Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma
• Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma
• A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
• Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma
• Effect of Montelukast in Asthma in Children
• The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma
• Pilot Study of How Children With Asthma Exacerbations Metabolize Prednisone
• A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma
• Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg
• Epinephrine Inhalation Aerosol USP, CLINICAL STUDY-B3 FOR ASSESSMENT OF PHARMACOKINETICS
• Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma
• Efficacy, Safety, and Pharmacokinetics of QAW039
• Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma
• Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma
• Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma
• A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)
• A Long-term Safety Study of Fluticasone Furoate (FF)/GW642444 and FF in Japanese Subjects With Asthma
• Real-world Effectiveness of Combination Therapies in Primary Care Asthma Management
• A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge Model
• Single Oral Dose of Dexamethasone Versus Five Days of Prednisone in Adult Asthma
• Antibiotic Treatment of Recurrent Episodes of Asthma in Children
• Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.
• Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway
• Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
• The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen
• Clinical Study to Explore the Efficacy of ACT-129968 in Patients With Partly Controlled Asthma
• Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
• Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3
• Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 2
• Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide
• The Use of Fractional Exhaled Nitric Oxide in the Identification of Non-adherence in Difficult Asthma
• Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations
• A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing
• Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients
• Acute Effect of Mometasone on Beta-adrenergic Airway and Airway Vascular Relaxation in Severe Asthma
• Inhaled Iloprost in Mild Asthma
• Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy
• Repeat Dose Safety Study for Compound to Treat Asthma
• A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients With Asthma
• A Study Comparative of Formoterol/Fluticasone Foraseq® and Fluticasone in Asthma Patients
• AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma
• A Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma
• Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients
• Pharmacokinetics in Adolescents
• Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
• A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)
• Comparative Study of Lung Bioavailability of HFA-Seretide Via Current Spacer Devices in Healthy Volunteers
• A Study on the Effects of a Single Dose of Prednisone on Biomarkers of Allergen Responses in Asthmatics (MK-0000-175)
• Fall Epidemic Viral Pediatric Study
• A Study Comparing the Pharmacokinetic, Pharmacodynamic and Safety of CHF 1535 (Fixed Combination of Beclomethasone + Formoterol) Administered Via the NEXT DPI, Versus the Free Combination of Licenced Beclomethasone DPI and Formoterol DPI in Asthmati
• Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma
• Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
• Study B2C112060: A Study of the Efficacy and Safety of Vilanterol Inhalation Powder in Adults and Adolescents With Persistent Asthma
• Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers
• Study of Preventive Treatment With Symbicort or Budicort Turbohaler in Childhood Asthma Return to School Epidemic
• A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
• Dose-Ranging Study of A006 DPI, in Adult Asthma Patients
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II
• Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma I
• Small Particle Steroids in Refractory Asthma
• Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA)
• A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in Asthma
• Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
• Oral GW766944 (Oral CCR3 Antagonist)
• Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents
• Efficacy of TPI ASM8 During a 14-Day Allergen Challenge
• Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol
• Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age
• Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Omalizumab in Japanese Children (6 - 15 Years)
• Study of Treatment of Depression in Refractory Asthma
• A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma
• HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents
• Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
• Asthma Control in Elderly Patients With Montelukast
• ATEM (Alvesco Non-interventional Study)
• Characterization of Placebo Responses in Stable Asthma
• Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy Volunteers
• Study of Asthma Phenotypes and Pharmacogenomic Interactions by Race-Ethnicity (SAPPHIRE)
• Real-world Effectiveness of Combination Therapy in Asthma
• Real-world Effectiveness and Cost-effectiveness of Leading Inhaled Corticosteroids in Asthma Management
• Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma
• A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo
• PPAR-gamma: a Novel Therapeutic Target for Asthma?
• Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
• Efficacy of QAX576 in Asthma
• Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response
• Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic Response
• Comparing Efficacy and Safety of Inhaled SNG001 to Placebo
• Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma
• Study of Asthma and Nasal Steroids
• Omalizumab in Non-atopic Asthma
• A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
• BI671800 in Asthmatic Patients on Inhaled Corticosteroids
• Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
• Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma
• Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA)
• To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study
• Investigation of Lung Ventilation Inhomogeneity in Pediatric Asthma
• A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
• Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma
• BI 671800 ED in Steroid-naive Asthmatic Patients
• Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
• Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids
• Risk Factors Associated to Difficult-to-control Asthma
• Asthma Exacerbation Study
• Efficacy and Safety of Different Doses of Indacaterol
• A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
• Beta Blockers for the Treatment of Asthma
• The Effect of Single Dose Paracetamol on the Lower Airways of Asthmatic and Healthy Children
• Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced Asthma
• Cross-over Study to Evaluate the Effect on Trough Forced Expiratory Volume in One Second (FEV1) After 4 Weeks Treatment With CHF 5188 pMDI qd in Adult Patients With Persistent Asthma
• Physiology of Cough in Asthma: Comparison of Sensory-Mechanical Responses to Mannitol and Methacholine Challenge Tests
• Early Airway Response to Allergen in Asthmatics (MK-0000-176)
• A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
• Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects
• Safety Study of Nebulized RNS60 to Treat Asthma.
• OC000459 Bronchial Allergen Challenge
• A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
• Controller Medications in the Management of Bronchial Asthma
• Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites
• The Study of Soy Isoflavones in Asthma
• Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma
• Randomized Controlled Trial of Silymarin in Asthma
• Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids
• Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)
• Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients.
• AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
• Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety Study
• Moderate to Persistent Asthma in the Obese Subject
• A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Maleate Via Concept1 or Simoon Devices
• Acute Montelukast in Asthma
• Trial for the Treatment of Acute Asthma in Wheezy Pre-school Aged Children
• Effect of Omalizumab in Patients With Severe Persistent Non-atopic Uncontrolled Asthma
• Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)
• COX-2 Inhibition in Allergic Asthma
• A Comparative Study Between Foraseq And Formoterol/Budesonide Inhalation Capsules in Patients With Asthma
• Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
• The Tolerability and Effects of AZD8848 in Allergic Asthma Subjects Challenged With Inhaled Allergen
• Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics
• Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma
• Study to Assess Airway Inflammation Effects of FlutiForm® pMDI Low and High Dose in Adults With Mild to Moderate Asthma
• Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma
• A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
• Inhaled Apocynin Decreases Reactive Oxygen Species Concentrations in Exhaled Breath Condensate in Mild Asthmatics
• Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma
• Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients
• Effect of PUR003 on Asthma
• Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma
• A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
• Utility of Versican and Hyaluronan Measurement in Induced Sputum as Biomarkers of Asthma
• Efficacy and Safety Study in Subjects With Asthma
• A Study to Assess the Safety and Tolerability of Multiple Doses of Multi-Level of a Drug in Subjects With Moderate Asthma
• Dexamethasone Tolerability in the Treatment of Acute Asthma in Children
• A Study To Assess The Safety And Effectiveness Of Medrol® In Acute Asthma In Indian Patients
• A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids
• Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
• A Study of RO5036505 in Patients With Moderate to Severe Asthma
• Usefulness of Exhaled Breath Condensate for Evaluation of Markers of Airway Inflammation in Children With Asthma
• Study of Salmeterol (SN408D) for Adult Asthma
• Sputum Matrix Metalloproteinases (MMP) mRNA and Montelukast
• A Study of the Safety and Effectiveness of JNJ-39758979 in the Treatment of Adults With Persistent Asthma
• A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics
• Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)
• Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)
• Comparison of Oral Dexamethasone Doses in Asthma Exacerbation
• Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma
• Study Evaluating the Effects of AIR645 on Allergen-Induced Airway Responses in Subjects With Mild Atopic Asthma
• Dose-response of Albuterol in Asthmatics
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients
• Study to Investigate Real Life Effectiveness of Symbicort Maintenance and Reliever Therapy in Asthma Patients Across Asia
• Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers
• Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma
• Time-Effect of Montelukast Protection
• A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
• Efficacy (Bronchoprotection) and Safety of Orally Inhaled BI 1744 CL in Patients With Intermittent Asthma
• Efficacy, Safety, Tolerability, and Pharmacokinetics of Indacaterol Salts in Patients With Asthma
• Advair Pediatric Once-Daily
• GSK BHR Study (Sont)
• Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)
• Concentrations of Salmeterol in Blood and Urine
• Terbutaline Concentrations in Blood and Urine
• Concentrations of Formoterol in Blood and Urine
• Effect of Add-on Montelukast to Inhaled Corticosteroids on Airway Responsiveness
• The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)
• Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients
• Steroid Sparing Effect of Nasal Corticosteroid In Asthma And Rhinitis
• FACTO Study (Foster® As Complete Treatment Option)
• Rapid Onset Action of Salbutamol Versus Formoterol
• Effects of Gallopamil in Severe Asthma
• OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
• CYT003-QbG10 for Treatment of Allergic Asthma Bronchial
• Staccato Loxapine Pulmonary Safety in Patients With Asthma
• A Study To Assess The Effect Of PF-03526299 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
• Effect of Montelukast on Remodelling Markers in Asthmatic Children
• Study to Evaluate the Safety and Efficacy of CAT-354
• Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma
• Ramelteon for Insomnia Comorbid With Asthma
• Next DPI LABA, Multicentre, 5-way Cross-over, Adult Asthmatic Patients
• Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease
• A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma
• Efficacy and Tolerability of Beclomethasone Dipropionate/Formoterol Single Inhaler in Patients With Mild to Moderate Persistent Asthma
• Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics
• Safety and Efficacy Study of Oral Senicapoc on Allergen Challenge in Atopic Asthmatic Subjects
• Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma
• A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma
• Saline Challenge in Monitoring Asthma Control
• A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics
• A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic Subjects
• Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic Patients
• Asthma Exacerbation Study
• Effects of Macrolides on Asthma Control
• GSK2190915 Moderate to Severe Asthma Study
• Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma
• Asthma Exacerbation and Helium-3 MRI
• Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma
• Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma
• Study to Investigate the Efficacy of Symbicort® SMART.
• Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
• Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients
• Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)
• Trough Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
• Peak Bronchoprotection Conferred by Levosalbutamol and Racemic Salbutamol
• Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma
• A Study To Examine The Safety And Efficacy Of PF-00610355 In Moderately Asthmatic Subjects
• Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients
• Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma
• Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma
• Ciclesonide for the Treatment of Airway Hyperresponsiveness
• Efficacy and Safety of Four Escalating Dose Regimens of TPI ASM8 in Patients With Allergic Asthma
• A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
• 4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma
• Bosentan for Poorly Controlled Asthma
• Efficacy, Safety and Pharmacokinetics of QAV680 in Asthma Patients
• A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise
• Study to Evaluate GSK2190915 in Subjects With Mild Asthma
• A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL
• The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma
• Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics (Glitz Asthma)
• A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects
• A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma
• Non-invasive Measures of Effects of Xolair in Asthma
• The Effect of Inhibition of B7-mediated Costimulation on Allergic Airway Inflammation in Mild Atopic Asthmatics
• MK0524 Asthma POC Study (0524-008)(COMPLETED)
• A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
• The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)
• To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)
• Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)
• Study to Evaluate the Inflammatory Cells Activity in Patients With Persistent Asthma Treated With Montelukast (0476-403)(COMPLETED)
• MK0633 Single Dose Study in Japanese Asthmatic Children Aged 12 to Less Than 16 Years (0633-028)
• Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma
• AZISAST Study: AZIthromycin in Severe ASThma Study
• One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids
• Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)
• The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)
• Study in Mild Asthmatic Patients
• A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005
• Single Dose Study of the Effect of Formoterol Fumarate in Combination With Mometasone Furoate Inhaled Via a Pressurized Metered Dose Inhaler (pMDI) in Children Aged 5-11 Years Old With Persistent Asthma
• The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)
• Effect of Salmeterol on Brain-Derived Neurotrophic Factor (BDNF) Concentrations in Asthma
• Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma
• Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma
• Nebulized Budesonide for Children Who Are Hospitalized for Acute Wheezing
• Budesonide for Emergency Treatment of Acute Wheezing in Children
• Viral Inception of Asthma: Prospective Study From Infancy to School-age
• Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma
• PF-04191834 Single Dose Bronchodilatory Study In Asthma.
• The Effects of Montelukast on Smokers With Asthma
• Effectiveness of Chinese Herbal Therapy for Asthma
• Vitamin D for the Treatment of Severe Asthma
• Pharmacogenetics of b2-Agonists in Asthma.
• The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
• MethaCholine Bronchoprovocation Study (MeCIS)
• Phase4/Symbicort® Versus Pulmicort Flexhaler® in African Americans
• A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)
• Effect of Montelukast on the Airway Remodeling
• Study of MAP0010 in Asthmatic Children and Adolescents
• A Study of 2 Doses of MAP0010 in Asthmatic Children
• Repeated High-dose Inhaled Corticosteroids for Asthma
• Effects of Budesonide & Budesonide/Formoterol on Smoking Asthmatic Subjects
• Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids
• Evaluation of Lovastatin in Severe Persistent Asthma
• Efficacy and Safety of Navarixin (SCH 527123) in Participants With Allergen-Induced Asthma (P05363)
• A New Modified-release Tablet Formulation of Prednisone (Lodotra®) in Patients With Nocturnal Asthma
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol
• Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol in Pediatric Subjects
• Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma
• Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
• A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma
• Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma
• Study Evaluating the Safety and Effects of MN-221 in Subjects With Moderate to Severe Asthma
• Influence of Propofol on Alveolar Macrophage in Asthmatic Patients
• CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)
• Effects of Montelukast in Children With Asthma
• A Study Designed to Determine if the Pharmacokinetic Disposition of Inhaled Insulin Exposure is the Same for Asthmatics and Non-asthmatics
• Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists
• Oral Nadolol for the Treatment of Adults With Mild Asthma
• Study Comparing Budesonide Hydrofluoroalkane (HFA) vs Chlorofluorocarbon (CFC) Pressurized Metered Dose Inhalers (pMDI) in Patients With Mild to Moderate Asthma
• Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects
• Efficacy and Safety of Levalbuterol Versus Racemic Albuterol in Asthma
• Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)
• Prednisolone Pharmacokinetics in Severe Asthma
• Inhaled Corticosteroids on Airway Smooth Muscle in Asthma
• A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma
• A Phase 1 Study of AIR645 in Healthy Subjects and Subjects With Controlled Asthma
• Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler
• The Effect of Xolair (Omalizumab) on Allergy Blood Cells
• A Phase I Study in Asthma Patients Evaluating the Effect of Doses of FlutiForm™ on the Amount, if Any, of Cortisol Produced by the Adrenal Glands
• Add-on Salmeterol Versus Montelukast in Arg/Arg-16 Asthmatics
• Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM
• Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5
• Titratable Dosing in Moderate to Severe Asthmatics
• Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5
• Symbicort in Asthmatic Children - SEEDLING
• A Study Comparing the Safety and Efficacy of Fluticasone and Formoterol Combination (FlutiForm™) With Fluticasone or Flovent to Treat Moderate to Severe Asthma in Adolescents and Adults
• A Study to Evaluate the Safety, Tolerability and Plasma Concentration Profiles of MK0633 in Asthmatic Children Aged 12 to Less Than 16 Years (0633-019)
• Symbicort Onset of Action 1
• Atlantis Symbicort
• Long-Term Safety of Symbicort in Asthmatic Children - SAPLING
• Gemini Symbicort pMDI
• Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
• Symbicort Onset of Action 2
• Dose-response of Inhaled Formoterol Using Methacholine Challenge as a Bioassay
• Evaluate Safety of Technosphere® Insulin (TI) in Diabetic Subjects With Moderate Obstructive Pulmonary Disease
• New Version Pulmicort Turbuhaler USA Adults
• New Version Pulmicort Turbuhaler USA Children
• Adults With Moderate to Severe Asthma
• Inhaled Steroid Treatment as Regular Therapy in Early Asthma
• Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children
• Varicella Vaccination With Pulmicort
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)
• Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma
• Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)
• Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients
• 4-Week Study of Efficacy, Safety and PK of Albuterol-HFA Versus Proventil-HFA in Pediatric Asthma
• Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics
• Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)
• Adult Asthmatics and Acid Reflux
• A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma
• Oral Glucocorticosteroid in the Treatment of Severe Asthma Exacerbation in Hospitalized Patients
• Safety and Blood Level Study of Unit Dose Budesonide
• The Effect of Allergen Inhalation on Sputum Myeloid and Plasmacytoid Dendritic Cells in Mild Atopic Asthmatics
• A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
• Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
• A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children
• Induced Sputum Study (0000-065)
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
• The Use of Rosiglitazone to Treat Asthma
• Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma
• Dose Response Effects of Inhaled Fluticasone on Airway Effects of Hypertonic-saline in Asthma
• Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
• Lansoprazole to Treat Children With Asthma
• Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
• A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy.
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy.
• Safety Study of Chinese Herbal Therapy to Treat Asthma
• Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.
• An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma
• Safety and Efficacy of QAX576 in Adults With Moderate Persistent Allergic Asthma
• Inflammatory, Functional and Image Composite Measure to Define Asthma Control
• How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment
• Study of the Mechanisms of Asthma
• Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
• Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
• Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
• Pulmicort Respules on Relapse Rates After Treatment in the ED
• Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD
• A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
• A Comparison of Levalbuterol Plus Ipratropium With Levalbuterol Alone in the Treatment of Acute Asthma Exacerbation
• Study on the Role of Treatment With Vitamin E on Asthmatic Responses in Allergic Asthmatics
• Albuterol HFA MDI in Pediatric Participants With Asthma
• Symbicort Maintenance and Reliever Therapy - Experience in Real Life Setting in Malaysia
• Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
• Zileuton and Exhaled Nitric Oxide in Asthmatics
• Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
• A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children
• Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma
• Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children
• Study Mild Intermittent Asthma to Assess the Topical Safety and Tolerability of Albuterol Sulfate Acu-30™ DPI
• Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)
• An Open, Randomised, Parallel Group Multicentre Study to Compare the Efficacy and Safety of Flutiform® pMDI vs Fluticasone pMDI Plus Formoterol DPI in Adolescent and Adult Subjects With Mild to Moderate-severe Persistent, Reversible Asthma
• Study of Inhaled Glucocorticosteroid Administration in Asthma Patients
• Study to Investigate the Effect of Inhaled Tiotropium Bromide on Neurokinin-A Induced Bronchoconstriction in Patients With Mild-to-moderate Asthma
• Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma
• Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications
• Bronchodilatory Efficacy of a Single Dose QMF149 (Indacaterol Maleate/Mometasone Furoate) Via the Twisthaler® Device in Adult Patients With Asthma
• A Study of 2 Doses of MAP0010 in Adult Asthmatics
• Spirometry and Methacholine Challenge Test in Asthmatic Children Age 3-6years
• Clinical Endpoint Trial Investigating Once Daily and Bronchodilator Dosing
• A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers
• Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)
• Tiotropium for Smoking Asthmatics Study
• Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma
• Singulair(R) In Asthma And Allergic Rhinitis (0476-383)
• First Step With Singulair® Therapy (0476-323)
• A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via TWISTHALER® Device in Adult and Adolescent Patients With Persistent Asthma
• Leukotriene Receptor Antagonists or Steroids in Pre-School Asthma
• A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)
• Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma
• Symbicort Rapihaler Therapeutic Equivalence Study
• Effect of Montelukast on the Expression and Variation of TGF-β for Children With Mild Persistent Asthma
• Open-Label Trial of the Use of Minocycline in the Treatment of Asthma
• Effects of AER 001 Administered by Nebulization on Antigen Challenge in Atopic Asthmatics
• A Phase IIa Study of Subcutaneous AER 001 on Antigen Challenge In Atopic Asthmatic Subjects (28 Day Study)
• Assessment of PFT, Safety, and PK of Zileuton Injection in Asthma Patients
• Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.
• Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
• Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma
• Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma
• Effect of Dietary Supplements With Fish Oil on Mannitol-induced Airway Sensitivity & Inflammation in Persons With Asthma
• Effect of Ciclesonide on Exercise Induced Bronchoconstriction
• Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma
• Effect of Budesonide on Exhaled Nitric Oxide in Asthmatic Children
• Nebulized Magnesium Sulfate in Pediatric Asthma
• A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)
• Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes
• Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen
• A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.
• Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects
• A Dose-Finding Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Adalimumab in Subjects With Refractory Asthma
• Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?
• Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
• Open-label, Safety and Efficacy Study of Pulmicort® Turbuhaler® in Japanese Children With Bronchial Asthma
• Study Of RV-39 In Patients Who Also Have Asthma
• Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation.
• Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms
• Clinical Trial of the Efficacy and Safety of Beclomethasone Dipropionate Plus Formoterol vs Fluticasone Propionate Plus Salmeterol in the 6 Months Step Down Treatment of Asthma
• A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced Asthma
• Prevention of Asthma and Allergy by Probiotic Lactobacillus GG
• Effect of Different Anti-Asthmatic Treatments on Lung Function and on Exercise-Induced Bronchoconstriction in Children With Asthma
• A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)
• Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma
• Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS
• Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
• Examine the Effect of Repeat Inhaled Doses of GW870086X on Lung Function in Mild Asthmatic Male Subjects
• A Study of MK0359 in Patients With Chronic Asthma (0359-013)
• Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients
• Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma
• Successful Control and Clinical Effectiveness Of SERETIDE(Salmeterol/Fluticasone Propionate) Study In Asthma.(SUCCESS)
• CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.
• Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
• Efficacy and Safety of Flutiform® pMDI in Adult Patients With Mild to Moderate-severe Reversible Asthma
• Study of FLUTIFORM® VS Seretide® in Paediatric Subjects With Asthma
• Childhood Asthma Research and Education (CARE) Network Trial - Montelukast or Azithromycin for Reduction of Inhaled Corticosteroids in Childhood Asthma (MARS)
• A Blinded Study To Examine The Ability Of PF-610,355 To Open The Airways In Asthmatic Patients.
• Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma
• Local Phase 4 Pan-European SMART Study
• Effect of Statins on Asthma Control in Smokers With Asthma
• A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients
• A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma
• SERETIDE 100/50 bd (Twice Daily) Versus FLIXOTIDE 100 bd As Initial Maintenance Therapy In Moderate Asthma In Adults
• Montelukast Back to School Asthma Study (0476-340)
• Efficacy of Formoterol vs Ipatropioum Bromide Plus Fenoterol in Children (5-<12 Years) With Acute Bronchial Obstruction
• Evaluation of the Utility of Minocycline as an Anti-Inflammatory Agent in the Treatment of Asthma
• No Resistance After Long Term Treatment SERETIDE
• SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)
• Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
• The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics
• A Study To Investigate The Effect Of Inhaled Fluticasone Propionate On The Bronchial Responsiveness To Leukotriene D4 In Asthmatics Patients
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg BID In Symptomatic Subjects With Asthma
• A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 mcg Twice Daily In Symptomatic Patients With Asthma
• A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects
• A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects
• Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-week) Study-
• Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
• Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)
• This Study Will Examine the Effects of GSK256066 to Protect Mild Steroid-naive Asthmatics Against an Antigen Challenge
• SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
• Single Dose GW685698X Magnesium Stearate Study In Asthmatic Patients.
• Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)
• Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)
• Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)
• A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)
• Lansoprazole to Treat Children With Asthma
• A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With Asthma
• Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease
• A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma
• Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma
• Safety Study of Anti-Asthma Agent BMEC-1217B
• Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
• Early Diagnosis of Asthma in Young Children
• Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)
• A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma.
• An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma
• Efficacy and Tolerability of Beclomethasone Dipropionate 100 µg + Formoterol 6 µg pMDI Via HFA-134a Vs. Budesonide 160 µg + Formoterol 4,5 µg Dry Powder Via Turbuhaler®. (Symbicort®)
• A Study Of GSK679586A When Infused Into Healthy And Mild Asthmatic Volunteers
• A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
• Determinants of Corticosteroid Insensitivity in Smokers With Asthma
• Inhaled Fluticasone Propionate: Effect on Parameters of Bone Metabolism in Patients With Mild to Moderate Asthma
• AKL 1 Asthma Study
• A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma
• Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)
• The Effect of MK0633 in Patients With Chronic Asthma (0633-007)
• Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
• Dose Ranging Study for Indacaterol in Japanese Asthma Patients
• Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma
• Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients
• The Anti-Inflammatory Effect of Extrafine HFA-Beclometasone Versus HFA-Fluticasone, by Means of Inflammometry
• A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)
• Study on the Effects of an AMP Challenge on Asthmatic Patients Following Treatment With Fluticasone Propionate
• A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS
• A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.
• To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)
• Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids
• Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis
• Linear Growth Study (0476-097)(COMPLETED)
• Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER)
• Asthma/Steroid Withdrawal Study
• Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)
• EFFICACY AND TOLERABILITY OF BECLOMETHASONE DIPROPIONATE 100 µg + FORMOTEROL 6 µg pMDI VIA HFA-134a vs. FLUTICASONE 125 µg + SALMETEROL 25 µg pMDI
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)
• (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA)
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma
• New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma
• Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma
• New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma
• Budesonide Inhalation Suspension for Acute Asthma in Children
• Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma.
• Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department
• Safety Study of a Vitamin E Supplement in Normal Volunteers and Those With Both Allergy and Asthma
• Symbicort Single Inhaler Therapy vs Conventional Best Practice for the Treatment of Persistent Asthma in Adults
• Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
• A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control
• A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)
• As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)
• Fish Oil and Asthma in House Dust Mite Allergy
• Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)
• Short- and Long Term Growth in Children With Asthma
• Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma
• Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)
• Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies.
• FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
• Spacer Comparison In Adult Asthmatics
• A Study To Determine The Effect Of SB-480848 On Asthma
• Chronic Bronchiolitis or Resistant Asthma?
• Evaluation of Traditional Paper Symptom Diary vs. the VOCEL Mobile Diary
• Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma)
• Study of Efficacy of Phenytoin in Therapy of Children With Bronchial Asthma
• An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma
• Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics
• Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data
• Cell Biology of Steroid Resistant Asthma
• Effect of Montelukast on Experimentally-Induced RV16 Infection in Asthma
• Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects
• Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids
• Montelukast Added to Standard Therapy for Acute Asthma in Children Age 6-14 Years
• A Comparative Study To Determine If Motivating Asthma Education (Compliance Enhancement) Has An Effect On Asthma Control
• Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
• Study Evaluating IMA-638 in Asthma
• Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)
• Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma
• Control of Asthma Patients Symptomatic on Inhaled Corticosteroids
• Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy
• Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
• Inhaled TPI-1020 Versus Inhaled Budesonide in Smokers With Mild Reversible Asthma
• Influence Of Different Airflow Resistances On Drug Effect Of 50μg Salmeterol And 6 μg Formoterol
• Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
• Study of Efficacy of Phenytoin in Therapy of Patients With Bronchial Asthma
• Prevention of Asthma Relapse After Discharge From Emergency
• Study of Oglemilast for the Treatment of Asthma
• Study of Oglemilast for the Prevention of Asthma.
• Evaluation of the Effect of Levalbuterol on Allergen Induced Airway Inflammation In Subjects With Atopic Asthma
• Childhood Asthma Research and Education (CARE) Network Trial - Acute Intervention Management Strategies (AIMS)
• Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
• Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
• Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)
• The Effect Of AVANDIA On The Late Asthmatic Response
• Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
• Viapaed Study In Children And Adolescents With Asthma
• A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)
• Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
• Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite
• Effect of Age and Device on Delivery of Fluticasone
• Chronic-dose Safety and Efficacy Study of a Bronchodilator Inhaler in Pediatric Asthmatics
• Impact of Anti-static Chamber/Mask
• Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101)
• Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101)
• Safety Study of Zileuton Injection in Patients With Asthma
• Study Of Patients With Allergic Rhinitis And Asthma
• Study Of Allergic Rhinitis In Patients Who Also Have Asthma
• The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563)
• Relative Potency of Inhaled Corticosteroids
• Statin Treatment in Patients With Asthma
• Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product
• SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
• Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
• SMILDA - Symbicort®Turbuhaler® Allergan Challenge Study in Allergic Patients With Mild Asthma
• Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma
• Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)
• A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy
• Effects of L-arginine Supplementation in Adults With Moderate to Severe Asthma
• TNF-alpha Directed Therapy in Asthma
• Dietary Supplementation With Soy Isoflavones in Asthma
• TNF Alpha in Refractory Asthma
• TELICAST : Telithromycin in Acute Exacerbations of Asthma
• Study In Asthma Control
• Study With GW274150 In Patients With Mild Asthma
• Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations
• Pediatric Asthma Controller Trial (PACT)
• Prevention of Early Asthma in Kids (PEAK)
• Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma
• Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
• AZMATICS: AZithroMycin/Asthma Trial In Community Settings
• Multiple Dose ASM8 in Mild Asthmatics
• Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
• Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
• Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics
• Elite Sport and Development of Asthma
• SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults
• SHARE - Symbicort and Health Economics in a Real Life Evaluation
• Oral Prednisolone Dosing in Children Hospitalized With Asthma
• Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma
• Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma
• DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
• STYLE - Symbicort Single Inhaler Therapy vs Conventional Therapy in Treatment of Persistent Asthma
• Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients
• Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics
• Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
• ASTHMA (AntibioticS To Help Manage Asthma) Pilot Study
• A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®
• Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg
• MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
• A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma
• Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
• Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
• SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
• A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
• Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting
• Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID
• PreAsthmaControl (PAC)
• Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression
• Efficacy/Safety Study of Nebulized IVX-0142, a Novel Antiallergic Drug, in Mild Allergic Asthma
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
• Study of Omalizumab in Moderate to Severe Bronchial Asthma
• MK0476 Study in Adult Patients With Acute Asthma (0476-322)
• A Study to Assess the Concentration of Budesonide in Breast Milk From Asthmatic Women
• Soluble CD23 Expression in Asthma Patients Treated With OMA
• Impact of Caregiver Depression on Asthma in the Child
• Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma.
• Study in Patients With Asthma
• Study in Patients With Asthma
• Study in Patients With Asthma
• Study in Patients With Asthma
• Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.
• Research in Severe Asthma (RISA) Trial
• Asthma Intervention Research (AIR) Trial
• Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma
• A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma
• Antiepileptic Drug Carbamazepine in Treatment of Bronchial Asthma
• The Role of GER in Exercise Triggered Asthma
• Mentored Patient-Oriented Research Career Development Award
• Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE)
• Treatment Of Symptomatic Asthma In Children
• Montelukast in Modulating Exacerbations of Asthma in Children
• Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
• Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
• Immune Dysfunction in Allergic Asthma
• Effect of an Inhaled Corticosteroid on Airway Gene Expression in Asthma
• LOMA: Long-Term Management of Asthma
• Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease
• Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
• Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma
• Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid
• Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.
• Sublingual Immunotherapy With House Dust Mite Extract in Asthmatic Children
• Study of Pulmozyme to Treat Severe Asthma Episodes
• Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
• Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)
• Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)
• Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)
• Efficacy and Safety of Ciclesonide in Preschool Children With Asthma (2 to 6 Years) (BY9010/M1-207)
• Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)
• Efficacy of Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (12 to 75 y) (BY9010/M1-142)
• Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)
• Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137)
• Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136)
• Effects of Inhaled Ciclesonide Versus Fluticasone Propionate Versus Placebo on Lower Leg Growth in Prepubertal Children With Mild Persistent Asthma (6 to 12 y) (BY9010/M1-208)
• Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)
• Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131)
• Effect of Inhaled Ciclesonide Versus Fluticasone Propionate in Patients With Mild to Moderate Asthma (18 to 65 y) (BY9010/M1-129)
• Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)
• Efficacy of Ciclesonide Inhaled Once Daily Versus Other Corticosteroids Used for Treatment of Mild Asthma in Children (4 to 11 Years) (BY9010/CA-101)
• A Pilot Study of Montelukast Sodium (Singulair) in Older Adults With Asthma or Chronic Obstructive Pulmonary Disease
• Effect of Anti-IgE in Non-Allergic Asthma
• Genetic Determinants of the Response to Salbutamol Among Asthma Patients
• Prevention of Asthma With Levocetirizine (36 Month Treatment) in Young Children Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and House Dust Mite and Having Completed the Previous EPAAC Trial (NCT00152464)
• Nitric Oxide (NO) Donors and Inhibitors Study: Study to Evaluate L-Arginine and Aminoguanidine in Asthmatic Subjects
• Effect of Symbicort on GR Localisation in Asthma
• Pediatric Asthma Study Using Stepwise Treatment With Two Food And Drug Administration Approved Asthma Medications
• Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD
• The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
• Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial Asthma
• Study of Efficacy of Gabapentin in Therapy of Bronchial Asthma
• Study of Efficacy of Sodium Valproate in Therapy of Bronchial Asthma
• Study of Efficacy of Lamotrigine in Therapy of Bronchial Asthma
• Efficacy and Safety of Tiotropium in Patients With COPD and Concomitant Diagnosis of Asthma
• Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)
• A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
• Trial of Asthma Patient Education (TAPE)
• The Impact of Dosimeter on Measurement of Airway Responsiveness to Methacholine
• Study of Efficacy of Oxcarbazepine in Therapy of Bronchial Asthma
• Study Evaluating Etanercept in Moderate to Severe Asthma
• A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)
• A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)
• A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma
• Immune Dysregulation in Children and Adults With Asthma
• The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma
• Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)
• Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic Asthma
• Rosiglitazone Versus Theophylline in Asthmatic Smokers
• A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)
• Predicting the Response to Montelukast by Genetic Variation in Asthmatics
• A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
• Evaluation of an Asthma Treatment Strategy Based on Exhaled Nitric Oxide Measurements in Adolescents
• Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
• A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma
• An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g
• Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
• Study Of Asthma In Patients Of African Descent
• A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)
• Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma
• Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children
• Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)
• An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)
• Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)
• Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)
• Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
• The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
• Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
• Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
• Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)
• Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients
• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)
• Study of Acid Reflux in Asthma
• Long Term Safety Study of Levalbuterol and Racemic Albuterol in Subjects Twelve Years of Age and Older With Asthma
• Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique
• Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma
• Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma
• Long-Term Safety Performance of Fexofenadine in Asthma
• Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
• Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma
• Borage Oil and Ginkgo Biloba (EGb 761) in Asthma
• Magnesium and Asthma - Clinical Trials
• Study of Daclizumab in Patients With Chronic, Persistent Asthma
• Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
• Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
• Study of TNFR:Fc (Enbrel) in the Treatment of Asthma
• Prevention of Early Asthma in Kids (PEAK)
• NHLBI/NICHD Collaborative Studies of Asthma in Pregnancy
• Asthma Clinical Research Network (ACRN)
• Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)